Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cannabis (1 trial)
cyclophosphamide (cytoxan) (2 trials)
fludarabine (fludara) (2 trials)
tm123 (1 trial)
unicar02-t (2 trials)
unicar02-t-ppsma (1 trial)
Disease Progression (Phase 1)
Kidney Neoplasms (Phase 1)
Leukemia (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Multiple Sclerosis (Phase 3)
Muscle Spasticity (Phase 3)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1)
Sclerosis (Phase 3)
Trials (3 total)
Trial APIs (6 total)